Development of a severity scale to assess chronic lung disease after extremely preterm birth
- PMID: 33729710
- PMCID: PMC8251957
- DOI: 10.1002/ppul.25279
Development of a severity scale to assess chronic lung disease after extremely preterm birth
Abstract
Objective: Chronic lung disease of prematurity (CLDP) is a frequent complication of prematurity. We aimed to identify what clinicians believe are the most important factors determining the severity of CLDP in extremely preterm infants (<28 weeks gestational age) after discharge from the neonatal intensive care unit (NICU) through 12 months corrected age (CA), and to evaluate how these factors should be weighted for scoring, to develop a CLDP severity scale.
Study design: Clinicians completed a three-round online survey utilizing Delphi methodology. Clinicians rated the importance of various factors used to evaluate the severity of CLDP, from 0 (not at all important) to 10 (very important) for the period between discharge home from the NICU and 12 months CA. Fourteen factors were considered in Round 1; 13 in Rounds 2 and 3. The relative importance of factors was explored via a set of 16 single-profile tasks (i.e., hypothetical patient profiles with varying CLDP severity levels).
Results: Overall, 91 clinicians from 11 countries who were experienced in treating prematurity-related lung diseases completed Round 1; 88 completed Rounds 2 and 3. Based on Round 3, the most important factors in determining CLDP severity were mechanical ventilation (mean absolute importance rating, 8.89), supplemental oxygen ≥2 L/min (8.49), rehospitalizations (7.65), and supplemental oxygen <2 L/min (7.56). Single-profile tasks showed that supplemental oxygen had the greatest impact on profile classification.
Conclusion: The most important factors for clinicians assigning CLDP severity during infancy were mechanical ventilation, supplemental oxygen ≥2 L/min, and respiratory-related rehospitalizations.
Keywords: Delphi panel; bronchopulmonary dysplasia; chronic lung disease; extremely premature; preterm.
© 2021 The Authors. Pediatric Pulmonology Published by Wiley Periodicals LLC.
Conflict of interest statement
Hugh M. O'Brodovich, Robin Steinhorn, Robert M. Ward, and Mikko Hallman were paid consultants to the Shire, a Takeda company, in connection with this study. Ethan J. Schwartz and Magdalena Vanya are employees of ICON and performed contracted research for the Shire, a Takeda company, in connection with this study. Ellen M. Janssen was an employee of ICON at the time the study was carried out. Linda Han is an employee of and owns stock/stock options in Takeda. Alexandra Mangili and Sujata P. Sarda were employees of Takeda at the time the study was carried out.
Figures



Similar articles
-
Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants.BMC Pediatr. 2019 Apr 30;19(1):138. doi: 10.1186/s12887-019-1515-6. BMC Pediatr. 2019. PMID: 31039810 Free PMC article.
-
Does chronic oxygen dependency in preterm infants with bronchopulmonary dysplasia at NICU discharge predict respiratory outcomes at 3 years of age?J Perinatol. 2015 Jul;35(7):530-6. doi: 10.1038/jp.2015.7. Epub 2015 Feb 26. J Perinatol. 2015. PMID: 25719546
-
Risk factors for neonatal bronchopulmonary dysplasia in extremely preterm premature rupture of membranes: a retrospective study.BMC Pregnancy Childbirth. 2020 Nov 3;20(1):662. doi: 10.1186/s12884-020-03366-0. BMC Pregnancy Childbirth. 2020. PMID: 33143671 Free PMC article.
-
Respiratory consequences of prematurity: evolution of a diagnosis and development of a comprehensive approach.J Perinatol. 2015 May;35(5):313-321. doi: 10.1038/jp.2015.19. Epub 2015 Mar 26. J Perinatol. 2015. PMID: 25811285 Free PMC article. Review.
-
Bronchopulmonary dysplasia: Rationale for a pathophysiological rather than treatment based approach to diagnosis.Paediatr Respir Rev. 2019 Nov;32:91-97. doi: 10.1016/j.prrv.2018.12.002. Epub 2018 Dec 19. Paediatr Respir Rev. 2019. PMID: 30745153 Review.
References
-
- Siffel C, Kistler KD, Lewis JFM, Sarda SP. Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review. J Matern Fetal Neonatal Med. 2019:1‐11. - PubMed
-
- Lapcharoensap W, Gage SC, Kan P, et al. Hospital variation and risk factors for bronchopulmonary dysplasia in a population‐based cohort. JAMA Pediatr. 2015;169(2):e143676. - PubMed
-
- Smith VC, Zupancic JAF, McCormick MC, et al. Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia. J Pediatr. 2004;144(6):799‐803. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources